Navigation Links
Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
Date:10/15/2007

r the nine month period ended August 31, 2006. The Company reported a net loss for the nine month period ended August 31, 2007 of approximately ($3.3 million), or ($0.29) per basic common share, compared to a net loss of approximately ($1.9 million), or ($0. 16) per basic common share, for the nine month period ended August 31, 2006. The net loss for the nine month period ended August 31, 2007 is attributable to a 7% increase in cost of sales and a 14% increase in marketing, general and administrative expenses partially offset by the 3% increase in revenue and a 23% increase in licensee income. In addition, the net loss in 2007 was increased by certain expenses in the 2007 period, including approximately $481,000 in research and development expenses, and approximately $194,000 in stock option compensation which is the result of the Company's adoption of FASB Statement No. 123(R).

The increase in cost of sales during 2007 period was in part due to expenses associated with the Company's introduction of U-Cord service enhancements, including return shipping by a medical courier for all new U.S. customers, and an increase in cord blood collection reimbursements. The increase in marketing, general and administrative expenses reflects the Company's previously announced strategic initiatives to strengthen the resources allocated to sales and marketing. This resulted in increased expenses associated with various marketing and sales initiatives. Also, contributing to the increase in marketing, general and administrative expenses were approximately $580,000 in professional fees associated with the proxy contest and approximately $126,000 in stock option compensation which is the result of the Company's adoption of FASB Statement No. 123(R).

The Company recognized approximately $779,000 in licensee income for the nine months ended August 31, 2007, compared to approximately $635,000 for the nine months ended August 31, 2006. Licensee income for the nine months ended
'/>"/>

SOURCE Cryo-Cell International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Fox, LLP says dangerous substances such as asbestos have been found ... ... York, NY (PRWEB) December 6, 2009 -- As parents shop for ... reports of recalls due to lead paint or asbestos contamination, says ... visit hospital emergency rooms each year due to toy-related injuries,” says ...
(Date:12/5/2009)... Babies, This Type of Blood Cancer Is Most Challenging-- ... Pediatric oncologists have identified specific genes, dubbed partner ... often-fatal form of leukemia in infants. By more accurately ... which infants may benefit from particular treatments. ,, ...
(Date:12/5/2009)... of International Solutions, an innovative new international private medical insurance plan ... addition to offering customers the flexibility to add or remove a ... Solutions enables customers to tailor their benefits to complement those already ... ...
(Date:12/4/2009)... Thousands of KPMG LLP employees came together in more than ... event which combines the audit, tax and advisory firm,s support ... day reflects our firm,s long history of volunteerism. Instead of ... to brighten the holidays for some children," said Tim Flynn, ...
(Date:12/4/2009)... KANSAS CITY, Mo., Dec. 4 The large, two-day free ... (NAFC) in Kansas City on Wednesday and Thursday is not ... uninsured and has not seen a doctor recently. All participants ... ,, "Many people who attended the three previous large free ...
Breaking Medicine News(10 mins):Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Free Health Clinic Event Is Not Just for the Sick 2
... Sept. 17 Law Offices of Howard G.,Smith announces ... on,behalf of shareholders who purchased the common stock of ... between February 12, 2007,and July 30, 2007 (the "Class ... States District Court for the Southern District of Ohio. ...
... CRME TSX: COM, VANCOUVER, Sept. 17 /PRNewswire-FirstCall/ ... that Bob Rieder, Chairman and Chief,Executive Officer, will ... Annual Growth Conference in San Francisco at 8:00am ... 2007. A live webcast of Mr. Rieder,s ...
... Cardiovascular Disease, Prevention and Treatment Options, and Global Trends That Undermine ... ... The upcoming episode of the "Charlie,Rose Science Series" on PBS will ... 900,000 lives each year in the United,States alone. Co-host Sir Paul Nurse, ...
... ATLANTA, Sept. 17 The Arthur M. Blank ... as program,officer of Better Beginnings. Better Beginnings, an ... children from birth through,age five, is one of ... to joining the foundation, Ms. Bertonaschi worked in ...
... 17 Metropolitan Jewish Geriatric Center,(MJGC) is proud to ... Work. Ms. Lerner brings valuable experience as well as ... She had been a unit,social worker at Shorefront Jewish ... she will be responsible for overseeing the Social,Work Department ...
... (Nasdaq: CSCX ), a global leader in ... it will present at the,UBS Global Life Sciences ... City.,The Company,s presentation is scheduled for Monday, September ... Matysik, senior vice president and chief,financial officer, will ...
Other Medicine News:Health News:Cardiome to Present at ThinkEquity Conference 2Health News:Cardiome to Present at ThinkEquity Conference 3Health News:Charlie Rose Science Series Explores Heart Disease 2Health News:Charlie Rose Science Series Explores Heart Disease 3Health News:Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings 2Health News:Cardiac Science to Present at the UBS Global Life Sciences Conference 2
(Date:12/4/2009)... MARLTON, N.J., Dec. 4 Thermographic Diagnostic Imaging ... in Marlton, New Jersey continues to provide superior ... thyroid, dental, TMJ and sinus regions to assist ... these areas. ,, Thermography utilizes infrared imaging ...
(Date:12/4/2009)... ,, PHILADELPHIA, Dec. 4 Teamster members employed ... are hard at work educating the public about the ... put Philadelphia,s blood supply at risk. More than ... picket line yesterday when their issues were ignored by ...
(Date:12/4/2009)... Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ... investor teleconference and webcast. Principal investigators will discuss ... multiple myeloma, as featured at the 51st American Society ... begin at 9:00 a.m. CT/10:00 a.m. ET on Monday, ...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 1Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 2Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 3Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 4Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 5Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 6Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 7Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 8Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 9Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 10Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 11Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 12Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 13Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6000 14The Minnesota Nurses Association 3A School Nurses in Minnesota Celebrate 100 Years of Addressing Health Needs of School Children 60726 1The Minnesota Nurses Association 3A School Nurses in Minnesota Celebrate 100 Years of Addressing Health Needs of School Children 60726 2United States Intervenes in False Claims Act Suit Against Virginia Medicaid Providers 60721 1United States Intervenes in False Claims Act Suit Against Virginia Medicaid Providers 60721 2
... N.J., May 7 Johnson & Johnson,will provide ... May 9,at 4:00 p.m. (Eastern Time) to coincide ... Tampa, Fla. Phase 3 clinical data presentations on,investigational ... analgesic, will be presented for the first time ...
... Individualized Treatment for ... Schizophrenia, ... VNDA ) investigational drug candidate,iloperidone, included its 4-week, short-term Phase ... trials, studying the efficacy,and safety of iloperidone. Iloperidone is a 5HT2/D2 ...
Other Medicine Technology:Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 2Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 3Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 4Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 5Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 6Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 7
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: